Flowers Foods (FLO) Q3 2024 (Q&A) earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 (Q&A) earnings summary
3 Feb, 2026Executive summary
Strong branded bread performance led to market share gains and unit growth, even as the overall category softened and net sales for Q3 2024 decreased 0.7% year-over-year to $1.191 billion.
Net income rose by $111.7 million to $65.0 million, mainly due to lower legal settlements and a reduced tax rate, with adjusted EBITDA up 10.0% to $133.3 million.
Margin improvement was driven by portfolio strategy execution, cost savings, and improved OEE, despite consumer headwinds and increased promotional activity.
Fiscal 2024 guidance was narrowed, reflecting greater certainty and strong branded retail bread performance.
Strategic focus remains on enhancing shareholder value through growth in branded retail, margin improvement in private label and away-from-home businesses, and cost savings initiatives.
Financial highlights
Q3 2024 net sales were $1.191 billion, down 0.7% year-over-year, with price/mix up 1.7% and volume down 2.4%.
Net income for the quarter was $65.0 million, a significant improvement from a net loss of $46.7 million in the prior year quarter.
Adjusted EBITDA rose 10.0% year-over-year to $133.3 million, with margin up 110 basis points to 11.2%.
Gross margin improved as production costs as a percent of sales decreased to 50.2% from 51.5% for the quarter.
Year-to-date cash from operations was $282.4 million; capital expenditures $86.6 million; dividends paid $152.5 million.
Outlook and guidance
Fiscal 2024 net sales expected between $5.116 billion and $5.147 billion, with adjusted EBITDA guidance of $530 million to $542 million and adjusted diluted EPS of $1.24 to $1.28.
Capital expenditures projected at $130 million–$140 million, with $5–$7 million for ERP upgrades.
Optimization initiatives are projected to save $40–$50 million in Fiscal 2024.
Effective tax rate expected at approximately 25%.
Category pressures are expected to be temporary, with normalization anticipated at some point in 2025.
Latest events from Flowers Foods
- All proposals passed with strong support, including board elections and a new equity plan.FLO
AGM 202629 May 2026 - Net sales up 1.1% to $1.572B, but net income down 20.6% amid higher costs and legal settlements.FLO
Q1 2026 (Q&A)23 May 2026 - Net income fell 27.4% as sales declined, but adjusted EBITDA rose 1.6% on margin gains.FLO
Q1 2025 Prepared Remarks22 May 2026 - Net sales up 1.1% but net income down 20.6% amid higher costs and market challenges.FLO
Q1 2026 Prepared Remarks21 May 2026 - Shareholders to vote on directors, executive pay, auditor, and new equity plan amid strong results.FLO
Proxy filing14 Apr 2026 - Key votes include director elections, executive pay, auditor ratification, and a new incentive plan.FLO
Proxy filing14 Apr 2026 - Q4 sales up 11% but net loss from impairment; 2026 outlook flat amid headwinds.FLO
Q4 2025 (Q&A)12 Apr 2026 - Q4 sales up 11% but net loss from $136M impairment; 2026 outlook cautious amid headwinds.FLO
Q4 2025 Prepared Remarks25 Feb 2026 - Net income up 5% and EBITDA up 7.8% on margin gains, despite flat sales and ongoing cost pressures.FLO
Q2 2024 (Q&A)23 Jan 2026